Taiwan FDA registration dc152bdaf2e90a6c164d1e5cc77ad76a
Taifu "Yilicha" single HBs testing reagent
TW: 台富"易利查"單株HBs 檢驗試劑
Taiwan·Taiwan Fu Pharmaceutical Co., Ltd·Registered Oct 06, 2005 – Dec 09, 2013CancelledRegistration details
- Analysis ID
- dc152bdaf2e90a6c164d1e5cc77ad76a
- Customs Code
- DHY00500180809
Company information
- Manufacturer
- Taiwan Fu Pharmaceutical Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- Enzyme immunoassay was used to determine type B surface antigen (HBsAg).
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- Domestic
Dates and status
- Registration Date
- Oct 06, 2005
- Expiry Date
- Dec 09, 2013
- Cancellation Date
- Apr 23, 2015
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Taifu "Yilicha" single HBs testing reagent in Taiwan's medical device market through Pure Global AI's free database. is registered under number dc152bdaf2e90a6c164d1e5cc77ad76a and manufactured by Taiwan Fu Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices